Nutritional changes in patients with locally advanced head and neck cancer during treatment

被引:52
|
作者
Arribas, L. [1 ,2 ,3 ,4 ]
Hurtos, L. [1 ,2 ]
Taberna, M. [2 ,3 ,4 ,5 ,6 ]
Peiro, I. [1 ,2 ]
Vilajosana, E. [3 ]
Lozano, A. [2 ,3 ,7 ]
Vazquez, S. [2 ,3 ,5 ]
Mesia, R. [2 ,3 ,4 ,8 ]
Virgili, N. [2 ,4 ,9 ]
机构
[1] Catalan Inst Oncol ICO, Clin Nutr Unit, Barcelona, Spain
[2] Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain
[3] Bellvitge Univ Hosp, Catalan Inst Oncol ICO, Head & Neck Canc Unit, Barcelona, Spain
[4] Univ Barcelona, Barcelona, Spain
[5] Catalan Inst Oncol ICO, Med Oncol Dept, Barcelona, Spain
[6] Catalan Inst Oncol ICO, Canc Epidemiol Res Program, Barcelona, Spain
[7] Catalan Inst Oncol ICO, Radiat Oncol Dept, Barcelona, Spain
[8] Catalan Inst Oncol ICO, Med Oncol Dept, Barcelona, Spain
[9] Bellvitge Univ Hosp, Nutr & Endocrinol Dept, Nutr & Dietet Unit, Barcelona, Spain
关键词
Clinical Oncology treatment; Head and neck cancer; Nutrition; Dietary counseling; Fat free mass; SQUAMOUS-CELL CARCINOMA; BIOELECTRICAL-IMPEDANCE ANALYSIS; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; ASSESSMENT PG-SGA; BODY-COMPOSITION; CHEMOTHERAPY; CHEMORADIOTHERAPY; CETUXIMAB; CACHEXIA; THERAPY;
D O I
10.1016/j.oraloncology.2017.06.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The purpose of the study is to evaluate changes in body composition and nutritional status that occur throughout the oncological treatment in head and neck cancer patients. Methods: A prospective cohort observational study in patients diagnosed with head and neck squamous cell carcinoma (HNSCC) that underwent treatment with induction chemotherapy (iCT) followed by chemoradiotherapy or bioradiotherapy were invited to participate. All patients had dietetic counseling from the diagnosis and a close monitoring throughout the treatment implementing nutritional support as needed. Results: From June 2011 until October 2012, 20 patients were included. Nutritional and anthropometric parameters were collected at diagnosis, post iCT, after radiotherapy, 1 and 3 months post radiotherapy. According to Patient Generated Subjective Global Assessment, 30% of patients were malnourished at diagnosis. After iCT there was an increase in weight, body mass index (BMI) and fat free mass (FFM) with almost complete improvement in dysphagia and odynophagia. Nevertheless a significant nutritional deterioration (p = 0.0022) occurred at the end of radiotherapy with 95% of patients becoming severe or moderate malnourished. Nutritional parameters such as weight, BMI and hand grip strength also decrease significantly during treatment. Conclusions: Despite an intensive nutritional support from the diagnosis throughout the oncological treatment in advanced HNSCC cancer patients, nutritional status deteriorates during radiotherapy. Our findings suggest that iCT may help improve nutritional status by ameliorating the symptoms that limit the oral intake. This improvement in the nutritional status could contribute to minimize further deterioration. Further investigations are needed involving novel approaches to avoid nutritional deterioration. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 50 条
  • [41] CLINICAL PROSPECTIVE STUDY OF VOLUME AND DOSIMETRIC CHANGES DURING FRACTIONATED RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER
    Albiac, M. Ramos
    Rovira, J. J.
    Calvo, E. Puertas
    Benavente, S.
    Beltran, M.
    Giralt, J.
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 : S37 - S37
  • [42] Chemotherapy advances in locally advanced head and neck cancer
    Georges, Peter
    Rajagopalan, Kumar
    Leon, Chady
    Singh, Priya
    Ahmad, Nadir
    Nader, Kamyar
    Kubicek, Gregory J.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (05): : 966 - 972
  • [43] Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients
    Le, T. Kim
    Winfree, Katherine B.
    Yang, Hongbo
    Marynchenko, Maryna
    Yu, Andrew P.
    Frois, Christian
    Wu, Eric Q.
    JOURNAL OF MEDICAL ECONOMICS, 2012, 15 (04)
  • [44] Radiotherapeutic management of locally advanced head and neck cancer
    Laskar, S. Ghosh
    Agarwal, J. P.
    Srinivas, C.
    Dinshaw, K. A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (03) : 405 - 417
  • [45] Induction chemotherapy in locally advanced head and neck cancer
    Shimizu, Yasushi
    Taguchi, Jun
    Kinoshita, Ichiro
    Tsuchiya, Kazuhiko
    Shirato, Hiroki
    Homma, Akihiro
    Fukuda, Satoshi
    Akita, Hirotoshi
    ANNALS OF ONCOLOGY, 2015, 26 : 33 - 33
  • [46] Amifostine -: A radioprotector in locally advanced head and neck cancer
    Schönekäs, KG
    Wagner, W
    Prott, FJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S170 - S170
  • [47] Locally advanced head and neck cancer: Combined chemoradiation
    Schafhausen, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 10 - 11
  • [48] Management of Locally Advanced or Unresectable Head and Neck Cancer
    Culliney, Bruce
    Birhan, Aminu
    Young, Amy V.
    Choi, Walter
    Shulimovich, Maxim
    Blum, Ronald H.
    ONCOLOGY-NEW YORK, 2008, 22 (10): : 1152 - 1161
  • [49] Induction chemotherapy for locally advanced head and neck cancer
    Calais, G.
    Chapet, S.
    Ruffier-Loubiere, A.
    Bernadou, G.
    CANCER RADIOTHERAPIE, 2013, 17 (5-6): : 498 - 501
  • [50] Nivolumab and ipilimumab in combination with radiotherapy in patients with locally advanced head and neck cancer
    Johnson, J. M.
    Bar Ad, V.
    Lorber, E.
    Luginbuhl, A.
    Curry, J. M.
    Cognetti, D.
    Keith, S.
    Axelrod, R.
    Zinner, R.
    Rodeck, U.
    Harshyne, L. A.
    Argiris, A.
    ANNALS OF ONCOLOGY, 2018, 29